semaglutide discovery found to increase risk of suicidal thoughts Novo Nordisk, the maker of

What side effects should I expect from GLP-1 medications

Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies

Daily routine: Morning: Topical GHK-Cu to scalp Evening: Topical GHK-Cu to scalp Every day: BPC-157 500mcg subcutaneous injection 3x per week: TB-500 2-5mg subcutaneous injection (maintenance dose) Bedtime: IGF-1 LR3 50-60mcg (4-6 week cycles with breaks) Additional: Weekly microneedling with GHK-Cu application immediately after Monthly progress photos and measurements Expected results: This is the most aggressive protocol

The truth is, standard BMI charts were designed for European populations

it provides context for a more informed conversation with your provider